FDA 483 - Neway Medical, P.C. - December 20, 2024

Neway Medical, P.C. in New York, NY, was inspected regarding its reproductive human tissue operations. The inspection revealed significant deficiencies in donor eligibility screening, testing, record-keeping, and associated procedures. These issues indicate a lack of robust controls to ensure the safety and eligibility of HCT/P donors and tissues.